These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38875217)

  • 1. The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
    Chicoine N; Schnipper N; Griffin J
    PLoS One; 2024; 19(6):e0304416. PubMed ID: 38875217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in general and COVID-19 vaccine hesitancy among U.S. adults from 2021 to 2022.
    Nguyen KH; Chung EL; McChesney C; Vasudevan L; Allen JD; Bednarczyk RA
    Ann Med; 2024 Dec; 56(1):2357230. PubMed ID: 38813804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19: talk of 'vaccine hesitancy' lets governments off the hook.
    Attwell K; Hannah A; Leask J
    Nature; 2022 Feb; 602(7898):574-577. PubMed ID: 35194212
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.
    Hossain MB; Alam MZ; Islam MS; Sultan S; Faysal MM; Rima S; Hossain MA; Mamun AA
    PLoS One; 2021; 16(12):e0260821. PubMed ID: 34882726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
    Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
    Front Immunol; 2021; 12():781161. PubMed ID: 34912346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
    Kim S; Lilani A; Redemptus C; Campana K; Tozan Y
    PLoS One; 2024; 19(5):e0300206. PubMed ID: 38709712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccine hesitancy and associated factors according to sex: A population-based survey in Salvador, Brazil.
    Nery N; Ticona JPA; Cardoso CW; Prates APPB; Vieira HCA; Salvador de Almeida A; Souza MMDS; Borba Dos Reis O; Pellizzaro M; Portilho MM; Rosa da Anunciação R; Victoriano R; Oliveira Dos Anjos R; Argibay HD; Carmo Lima DO; Mesquita IL; Conceição WM; Santana PM; Oliveira EC; Santana PSN; Brodskyn CI; Mothé Fraga DB; Solcà MDS; Reis MG; Costa F; Ribeiro GS
    PLoS One; 2022; 17(1):e0262649. PubMed ID: 35061811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.
    Shen AK; Hughes Iv R; DeWald E; Rosenbaum S; Pisani A; Orenstein W
    Health Aff (Millwood); 2021 Jan; 40(1):62-69. PubMed ID: 33211542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
    Aggarwal S; Singh L; Alam U; Sharma S; Saroj SK; Zaman K; Usman M; Kant R; Chaturvedi HK
    PLoS One; 2024; 19(5):e0294480. PubMed ID: 38722922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
    Trent M; Seale H; Chughtai AA; Salmon D; MacIntyre CR
    Vaccine; 2022 Apr; 40(17):2498-2505. PubMed ID: 34218963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine acceptance and hesitancy in Indian context: a systematic review and meta-analysis.
    Dey S; Kusuma YS; Kant S; Kumar D; Gopalan RB; Sridevi P; Aggarwal S
    Pathog Glob Health; 2024 Mar; 118(2):182-195. PubMed ID: 38014567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
    Sasse K; Mahabir R; Gkountouna O; Crooks A; Croitoru A
    PLoS One; 2024; 19(6):e0301488. PubMed ID: 38843170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom.
    Nguyen LH; Joshi AD; Drew DA; Merino J; Ma W; Lo CH; Kwon S; Wang K; Graham MS; Polidori L; Menni C; Sudre CH; Anyane-Yeboa A; Astley CM; Warner ET; Hu CY; Selvachandran S; Davies R; Nash D; Franks PW; Wolf J; Ourselin S; Steves CJ; Spector TD; Chan AT;
    Nat Commun; 2022 Feb; 13(1):636. PubMed ID: 35105869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective.
    Gerussi V; Peghin M; Palese A; De Martino M; Graziano E; Chiappinotto S; Fonda F; Bontempo G; Semenzin T; Martini L; Isola M; Tascini C
    Hum Vaccin Immunother; 2024 Dec; 20(1):2358565. PubMed ID: 38825984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics.
    Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S
    Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Meso-Level Factors on SARS-CoV-2 Vaccine Early Hesitancy in the United States.
    Kaliba AR; Andrews DR
    Int J Environ Res Public Health; 2023 Jul; 20(13):. PubMed ID: 37444159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing efforts beyond tailored promotional campaigns by understanding contextual factors shaping vaccine hesitancy among equity-deserving populations in Canada: an exploratory qualitative study.
    Nascimento LG; Dubé È; Burns KE; Brown P; Calnan M; Ward PR; Filice E; Herati H; Ike NAU; Rotolo B; Meyer SB
    Int J Equity Health; 2023 Oct; 22(1):209. PubMed ID: 37805472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
    Carcelen AC; Prosperi C; Mutembo S; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Chilumba I; Musukwa G; Thuma P; Kapungu K; Hamahuwa M; Mutale I; Winter A; Moss WJ; Truelove SA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34227914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient concerns and physician strategies for addressing COVID-19 vaccine hesitancy.
    Melnikow J; Padovani A; Zhang J; Miller M; Gosdin M; Loureiro S; Daniels B
    Vaccine; 2024 May; 42(14):3300-3306. PubMed ID: 38627148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.